Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder
Phase: PHASE2 | Sponsor: University of Texas at Austin | Compound: Psilocybin
- Status
- recruiting
- Institution
- University of Texas at Austin
- Start date
- 2025-01-10
- End date
- 2030-12-31
- Registry ID
- NCT06132178
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.